March 22, 2018 / 4:53 PM / a month ago

BRIEF-Astrazeneca Says Lokelma Approved In The European Union

March 22 (Reuters) - Astrazeneca Plc:

* LOKELMA APPROVED IN THE EU

* ‍LOKELMA APPROVED IN EU FOR TREATMENT OF ADULTS WITH HYPERKALAEMIA​

* ‍EUROPEAN COMMISSION HAS GRANTED MARKETING AUTHORISATION FOR LOKELMA​

* ‍APPROVAL FOR TREATMENT OF ADULTS WITH HYPERKALAEMIA​

* ‍LOKELMA IS CURRENTLY UNDER SEPARATE REGULATORY REVIEW IN US, WITH A DECISION EXPECTED IN FIRST HALF OF 2018​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below